IL17A and arthritic joint disease: After treated with enrofloxacin, significant alteration in cytokine expressions were detected, including higher levels of IFN-γ and IL-17A in arthritis model mice (Dorozynska et al., 2014) and higher TNF-α, IL-1β levels in chicken models (Wisselink et al., 2017).